drugset / Trial / NCT00566150

Levetiracetam in the Management of Bipolar Depression

NCT00566150

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A 6-week outpatient, double-blind, placebo-controlled, add-on trial to investigate the effects of levetiracetam on depressive symptoms in bipolar depressed patients.

Timeline

Start
2005-10
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levetiracetam Other / unclassified 2500 mg

Indications